GLP-1 drugs may slow biological aging by two to three years, early research finds
Findings presented in Boston suggest users have biological-age markers younger than comparable untreated people. The signal comes as safety questions grow: lawsuits allege sudden vision loss, and studies have linked the drugs to hair loss and nail disorders.
2 min read